Keratoconus has increased in frequency over the years. Keratoconus now occurs 1 in 500 people vs 1 in 2000 in the past (that’s a 400% greater frequency now).
If you answered YES to any of the above, then Keratoconus is significantly affecting your life.
If your doctor NEVER mentioned the non-invasive Holcomb C3-R® & Intacs® to you, then you are just as frustrated as we are.
In 2003, Dr. Brian invented Holcomb C3-R®, the first non-invasive corneal crosslinking procedure for Keratoconus which has the longest track record of ANY form of crosslinking in the world (except Germany).
Many cornea transplant surgeons (whose practice is based on performing invasive cornea transplants) don’t want you to know about Holcomb C3-R® since it can PREVENT you from needing a cornea transplant.
For over a fifteen years, Dr. Brian has been educating eye doctors around the world by speaking at scientific meetings and presenting his results of these procedures that he pioneered since 1999. He’s published articles in the medical literature and ophthalmology and optometry trade journals. He’s the author of THE book on Keratoconus, Modern Management of Keratoconus.
Dr. Brian has been the expert on numerous national television (Good Morning America, Today Show, NBC Nightly News, EXTRA, Dr. Drew’s LifeChangers to name just a few) and radio shows (NPR, Voice of America, etc) discussing his proprietary modern treatments for Keratoconus that can improve vision and save people from cornea transplants.
If you are worried about needing a cornea transplant in the future, then continue reading.
And there was the worldwide tsunami of media attention after our Keratoconus patient Steven Holcomb won Gold in 2010 at Vancouver Olympics and double Bronze medals at the 2014 Sochi Olympics. Before he won these Olympic medals, Steven had to give up being an athlete. Steven tells how demoralized he was after 12 other eye doctor “specialists” told him his only option was a cornea transplant. His coaches and United States Olympic Team found Dr. Brian and, well, you know the rest of the story.
So if your doctor never heard of Holcomb C3-R®, Intacs®, and CK, then frankly your doctor is likely not keeping up with the Keratoconus field. Even worse – most cornea transplant surgeons don’t want you to know about Holcomb C3-R® because their livelihood depends on doing cornea transplants. It’s the unfortunate truth.
But the good news for you is that YOU did your research and you are here now and discovered these revolutionary treatments that can improve your vision and save you from needing a cornea transplant.
These minimally involved ways can treat your Keratoconus and stop it’s worsening as it has for many, many thousands of people who flew here for Dr. Brian’s gifted hands to help them. This creates tremendous peace-of-mind for people to know their Keratoconus is stable and won’t likely progress anymore. Wouldn’t it be wonderful to never stay awake at night stressing about needing a cornea transplant?
Thousands and thousands of Keratoconus patients have already found the solution in a non-invasive process: Holcomb C3-R® Crosslinking System.
You might be thinking, “Why would someone fly to see Dr. Brian in Beverly Hills?” Answer: 25-30 good people just like you EVERY MONTH travel to see TRUSTED Dr. Brian to treat them and improve their vision, and prevent them from needing a cornea transplant in the future.
Sure you’ll be able to find someone near you so can try to treat you (many surgeons will happily jump at the chance to do procedures especially since Obamacare is affecting their practices), but the reason that 25-30 people every month hop on a plane for the easy 3-day trip is because they want to be treated by the doctor who INVENTED these procedures, who has the longest track record in the world. On a weekly basis people arrive in our office from out-of-town. They come from all over the United States (West Coast, Midwest, East Coast, and the South) and from other countries such as Canada, Europe, Asia, South America, Africa, and as far away as Australia. Every week, people come. Week after week. Year after year. Now decade after decade.
Dr. Brian is recognized as a Keratoconus specialist and as well as the “Guru of Modern Crosslinking.” Good people like yourself, who have Keratoconus signs and want to undergo treatment, routinely travel from all parts of the United States, Canada, and outside countries because he developed Holcomb C3-R® Crosslinking System in 2003 which strengthens the compromised cornea that occurs with Keratoconus (see Presentation and Research Articles link). This is accomplished by increasing corneal collagen crosslinking, which are the natural “structural anchors” within your cornea. And best of all: this is done WITHOUT surgery with Dr. Brian’s advanced technique. The anchors prevent your cornea from further bulging and becoming more distorted (which is the cause of Keratoconus). The only place to have the Holcomb C3-R® Crosslinking System is at the Boxer Wachler Vision Institute in Beverly Hills, California.
In 2003, Dr. Brian developed the Holcomb C3-R® Crosslinking System – the out patient, 30 minute, NON-invasive procedure to have higher safety for patients than CXL where the epithelium is disrupted. Holcomb C3-R® Crosslinking System is SAVING people from significant pain and induced blurred vision during the first month that happens when the epithelium is removed. Dr. Brian invented the “epi-on” or transepithelial crosslinking technique in 2003 because he saw the pain and problems people were having from cross linking with removal of epithelium.
During Holcomb C3-R®, our proprietary Crosslinking Solution (containing riboflavin and other compounds) is applied to the cornea, which is then activated by a special light.
As it was developed in 2003, Holcomb C3-R® Crosslinking System retains the longest track record of ALL of cross-linking procedures in the U.S., Canada, South America & Latin America, Europe (with the exception of Germany), and Asia. With the Holcomb C3-R® Crosslinking System you can rest as easy as a baby wrapped in a warm blanket that you are getting “the real thing” that was developed by modern crosslinking guru, Dr. Brian.
In addition, Dr. Brian invented a special process where both of your eyes can be treated at the same time. With the Holcomb C3-R® Crosslinking System you won’t have to return on a different day for the second eye to be treated (which as you can imagine is very inconvenient to your daily routine).
The Holcomb C3-R® Crosslinking System is special and proprietary – it is only available at our office – it is not available anywhere else.
Dr. Brian developed a proprietary Crosslinking Solution that is one of several keys to its success. Holcomb C3-R® is protected by the United States Patent and Trademark Office.
Removing the epithelium (as done with CXL) creates a painful recovery and significantly increases risk of infection, corneal haze, scarring, and corneal nerve trauma requiring 6 months to recover. The non-invasive Holcomb C3-R® allows patients to return to their normal routine the next day! Our studies and studies of other eye doctors have shown patient results are not significantly different with crosslinking with removal of epithelium vs. leaving epithelium undisturbed in its place. Therefore, it is not necessary to scrape off the epithelium for crosslinking and is safer without scraping off your epithelium.
The risk of the Holcomb C3-R® Crosslinking System is mild irritation for a couple of days. And most people NEVER even experience that. That’s it.
The complication rate of “epi-off” (removal of epithelium) CXL crosslinking procedure was recently reported to be high at 11%. Complications of CXL include:
1) severe pain
2) corneal infection and ulceration
3) corneal haze
4) delayed epithelial healing
5) worse, more blurry vision
6) cornea nerve damage persists even 5 years after CXL
7) permanent corneal scarring
8) induced visual distortions
9) peripheral flap melting in patients who had previous LASIK and flap dislodgement
10) cornea swelling that never goes away
11) damage to iris causing change in eye color
12) extended light sensitivity
13) cornea perforation (hole was accidentally made through entire thickness of cornea)
The above CXL complications have NEVER occurred with the Holcomb C3-R® Crosslinking System.
The retreatment rate with the Holcomb C3-R® Crosslinking System is 0.7% (less than 1%) which is significantly less than Epi-off CXL which have retreatment rates as high as 7%. Why the much lower retreatment rate with Holcomb C3-R®? There are two powerful reasons:
1) Dr. Brian customizes the energy level he uses for each patient, so he customizes the amount of crosslinking for your eyes. He is the ONLY doctor who can do this. OTHER DEVICES THAT DOCTORS USE ONLY HAVE A SINGLE (LOW) ENERGY SETTING THAT THEY CANNOT CHANGE. As a result, a number of people who have CXL elsewhere unfortunately are “under-crosslinked” which is the reason the rate of Keratoconus worsening is SIGNIFICANTLY higher with CXL than Holcomb C3-R®. Holcomb C3-R® gives you “peace-of-mind.”
2) Holcomb C3-R® Crosslinking System covers the greatest corneal area for crosslinking – it covers 157% more surface area of the cornea compared to other techniques such as CXL. This allows for a more complete area of treatment which is important since Keratoconus extends into the periphery of your cornea . We make sure we treat your central cornea areas as well as the far periphery of your corneas with the Holcomb C3-R® Crosslinking System.
This is the reason that 99.3% of people are stabilized with just a single treatment with Holcomb C3-R® versus CXL stabilizing ONLY 71.6% of cases.
3) Some doctors are now “trying” epi-on crosslinking. Do not be fooled. 1) They are using solutions that do NOT have the long track of the proprietary solution used in Holcomb C3-R® and 2) Those epi-on patients are being “under-crosslinked” because the device these doctors use has ONLY a LOW energy setting. Epi-on crosslinking MUST be done with higher energy levels to produce more crosslinking. Dr. Brian’s Holcomb C3-R®, invented in 2003, does that and THAT is part of the reason the success rate of Holcomb C3-R® is 99.3%.
Dr. Brian was selected to give a prestigious TEDx talk about how he fought on behalf of patients diagnosed with Keratoconus (a degenerative eye disease), to pioneer the Holcomb C3-R® procedure to save them from cornea transplants. He described the emotional battle and what he had to overcome to make Holcomb C3-R® the widely accepted procedure that it is today for patients with Keratoconus.To watch Dr. Brian’s TED talk “Fight For Sight,” simply click on the video below:
CXL is a SURGICAL procedure. In contrast, Holcomb C3-R® is NON-surgical hence NO COMPLICATIONS.
Holcomb C3-R® Crosslinking System is a routine part of our practice and has been so for over 10 years. Since Holcomb C3-R® is NOT in a study – our patients are not required to have the multiple “back and forth” office visits which can be quite time-consuming and disruptive to one’s school or work schedule.
Dr. Brian discovered that different degrees of Keratoconus require different amounts of crosslinking. As a result, another proprietary feature of Holcomb C3-R® Crosslinking System is that he customizes the energy level (amount of crosslinking) for each eye of each patient. Dr. Brian is the only doctor in the world who does this with crosslinking.
With Holcomb C3-R® Crosslinking System you can be confident in receiving the optimized level of crosslinking treatment for each of your eyes (vs. the “one size fits all” approach of same energy level for all eyes of all patients with all the other crosslinking techniques including CXL).
The Holcomb C3-R® Crosslinking System can also be combined with Intacs® to flatten the keratoconus cone even more than with Intacs® alone. We routinely perform these both procedures on the same day. In these cases, the Holcomb C3-R® Crosslinking System can stabilize keratoconus from getting worse as well as help the Intacs® reverse part of the Keratoconus steepening that had already occurred up to the time of the treatment. The combination of same-day Intacs® and the Holcomb C3-R® Crosslinking System can give you the ideal results of improved vision AND stability.
Some patients take a “wait and see” approach with Keratoconus. The risk of waiting is that as the cornea continues to bulge out and get worse, the back layer of the cornea can rip open – like someone wearing way too tight pants who sits down and the pants split wide open down the middle seam. When this happens to the progressively bulging cornea, the internal eye liquid rushes in and swells up the cornea the same way a dry sponge soaks up water and becomes very thick.
These photos below show a cornea swollen up like a soppy, wet sponge after it split open. If this happens to you, it will take 3-6 months of non-usable vision until this fluid goes away. When it eventually does, the cornea will have a lot of new scarring and vision will be permanently worse compared to before it ripped open. The good news is that this devastating damage can easily be prevented with the 30-minute, non-invasive, 1-day recovery Holcomb C3-R® – it will give you important peace-of-mind.
You don’t have to worry as much as someone suffering from contact lens issues, BUT YOU STILL HAVE TO WORRY.
Keratoconus is unpredictable and progressive. “It has a mind of its own” since it doesn’t follow any rules. Holcomb C3-R® would be recommended at a minimal to strengthen your cornea and not to worry about future vision loss. It is like an “insurance policy for your eyes.” Thousands of good people like yourself now sleep as sound as a baby wrapped in a warm blanket after having Holcomb C3-R®.
This below case of worsening occurred in a young woman, but could have been prevented. After consultation with Dr. Brian, she saw another eye doctor in Los Angeles who was uninformed and advised her not to have Holcomb C3-R®. The result: significant vision loss from delay of treatment for over 1 year. She came back for Holcomb C3-R® which stopped the worsening and further vision loss. Unfortunately she won’t regain the vision she lost during the one year of delay.
Dr. Brian is credited as the first doctor in the world (except Germany) to use corneal crosslinking treatments for Keratoconus as well as being the first doctor in the world to combine this treatment with Intacs®. As the inventor of transepithelial Holcomb C3-R® Crosslinking in 2003 – Dr. Brian has the longest crosslinking track record of any doctor in the United States, Canada, Asia, Latin America & South America, and Europe (except for Germany).
People who want the best possible treatment for their eyes choose Dr. Brian. With the Holcomb C3-R® Crosslinking System you can rest assured that you’ll be receiving the crosslinking procedure with the longest track record in the world (except for Germany).
Dr. Brian is considered the “Guru of Modern Crosslinking” because of his extensive experience and expertise. Would you trust your precious eyes and the future of your vision to someone who just learned how to do the procedure?
Patients come to us from all over the United States and from other countries.
Some people you like the most in your life may say to you, “Why would you fly out to Beverly Hills?” in the guise of helping you. Unfortunately they don’t know the facts of how Keratoconus is affecting or threatening to affect your life. They have no idea what it’s like to ‘walk in your shoes’ because having Keratoconus is like being a stranger in an unfriendly, strange land.
The Holcomb C3-R® Crosslinking System is the only crosslinking procedure with a Gold Medal behind it. The U.S. Bobsled Team effectively endorsed the procedure when they paid 100% of the fee for U.S. Bobsledder Steven Holcomb to have it to save his eyesight – the procedure now bears his name in honor of what Steven accomplished after overcoming his Keratoconus.
Finally, you can overcome your Keratoconus as well.
Many out-of-town patients would like Dr. Brian to do a complimentary review of their medical records and make a preliminary determination of candidacy. This is useful before planning an easy, 3-day trip to Beverly Hills.
No matter where you live, you essentially are just in “our backyard.” You are just like so many people who all the time fly or drive to see Dr. Brian.
Some people’s friends ask them, “Why are you thinking of traveling to Beverly Hills for your Keratoconus treatments?” Although well-meaning, friends and family have no idea what it’s like to live with Keratoconus. People usually respond back to friends and family with, “I deserve the BEST and I want to go to the BEST doctor who has the MOST experience, who invented these procedures. I only have two eyes and I want the best for them!”
A records review is easy and the first step to better vision. Here’s how to submit them to Dr. Brian:
These are the three easy steps:
Boxer Wachler Vision Institute
Keratoconus Record Review
465 N. Roxbury Drive, Suite 902
Beverly Hills, CA 90210
Or you can scan your records and email them to [email protected]
In 2010 Dr. Brian was honored along with his patient, Olympic Gold Medalist Steven Holcomb. Both are credited to increasing awareness in 2010 for modern Keratoconus treatments. The Jules Stein Living Tribute Award was presented to Dr. Brian for pioneering alternative treatments to the painful cornea transplant for Keratoconus patients. Steven Holcomb was presented with the Athlete of Vision Award for raising awareness that Keratoconus can be treated and vision restored. Steven had retired from bobsledding in 2007 when Keratoconus began to drastically affect his ability to safely drive his bobsled at mock speeds. Steven’s coaches knew Steven was the best hope for Olympic Gold so they researched the Keratoconus options and discovered Dr. Brian.After being treated by Dr. Brian in 2007, Steven went on to win World Cup events in 4-man bobsled and then triumphed at the 2010 Winter Olympics securing the Gold Medal in the 4-man bobsled event, the first for the USA in 62 years. At the Vision Awards several celebrities were presenters, including Will.i.am of the widely popular music group the Black Eyed Peas. Other honorees that evening included Buzz Aldrin (astronaut & 2nd person to walk on the moon), Lilly Tomlin (comedienne, best know for her characters Ernestine and Edith Ann on the show Laugh-In) and Steve Jobs (former Apple CEO).